Braftovi 75 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB25FB5TL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,131
Award facts
- Contract value 100% obligated
- $10,131.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Braftovi 75 mg capsules (90-count units) valued at $10,131.00, with completion targeted for October 20, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Braftovi is a prescription medication used in oncology treatment, reflecting the company's role in supplying specialized pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued as a child contract under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's substantial IDC demonstrates its capability to fulfill federal procurement requirements through competitive awards and positions the company as a critical pharmaceutical distributor within the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FB5TL?
SPE2DB25FB5TL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FB5TL worth?
The government has obligated $10,131 on SPE2DB25FB5TL.
Is contract SPE2DB25FB5TL an order under another contract?
Yes. SPE2DB25FB5TL is a delivery order under SPE2DB24D1007, an indefinite delivery contract.
Was contract SPE2DB25FB5TL competed?
The extent of competition for SPE2DB25FB5TL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award